DCM Shriram's Q1 FY27 revenue grew 9% to ₹3,564 Cr, PBDIT rose 12% to ₹364 Cr.

PAT was ₹693 Cr, with normal PAT at ₹147 Cr (after adjustments). Chemicals and Fenesta drove revenue growth.

Capex cycles are commissioning, improving integration for future value creation.